Red yeast rice to help lower LDL and raise HDL cholesterol

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, double‑blind, placebo‑controlled, parallel trial recruiting about 80 adults with LDL‑C 130–190 mg/dL and low HDL‑C, who will take either ANKASCIN 568‑P red yeast rice capsules or a matching placebo for 24 weeks. Participants will take two capsules daily (each capsule contains 440 mg ANKASCIN 568‑P) and undergo biochemical blood testing at baseline and at weeks 4, 12, and 24. The study will monitor blood lipids, blood glucose, blood pressure, body measurements, and liver, kidney, and thyroid function to track safety and overall health. There is a screening period before treatment and a discontinuation follow‑up after the 24‑week treatment period.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Male or Female women over the age of 20 (women of childbearing age should not be pregnant or breastfeeding during the study period).
* A sane and communicative adult.
* 18≦BMI≦35.
* Sub-healthy people with simple dyslipidemia and those who have been judged by the doctor that they do not need to take hypolipidemic drugs for the time being, or those who insist on not taking drugs.
* Screening criteria Low-density lipoprotein cholesterol (LDL-C): 130\~190 mg/dL. screening criteria and high-density lipoprotein cholesterol (HLDL-C): below 50 mg/dL.
* Those without other serious diseases (cancer, heart failure, diabetes, myocardial infarction, liver cirrhosis, moderate to severe liver and kidney dysfunction, stroke, etc.).
* During the experiment, the daily routine and eating habits should be maintained and not changed deliberately.

Exclusion Criteria:

* Triglyceride TG≧500 mg/dL.
* Blood pressure value: systolic blood pressure ≧ 200 mmHg or diastolic blood pressure ≧ 140 mmHg.
* Patients with moderate or severe abnormal liver and kidney function (generally referring to serum aminopyruvate converting enzyme (SGPT), serum glutamate phenylacetate transaminase (SGOT) are more than 3 times the upper limit of normal or have been diagnosed Liver cirrhosis, or glomerular filtration rate eGFR≦30 ml/min/1.73m2).
* Pregnant or lactating women.
* Those who take traditional Chinese medicine mainly based on red yeast rice.
* Those who have undergone surgery within one month.
* Those who have serious diseases such as heart, liver, kidney, and hematopoietic system, mentally ill patients who do not meet the inclusion criteria, fail to use the test product according to the regulations so that the efficacy or safety cannot be judged due to incomplete data.

Where it's running

• Tri-Service General Hospital, National Defense Medical Center, Taipei city,
  Taipei, Taiwan Recruiting

Study contacts

• Principal investigator: WEN-HUI FANG, Ph. D. — Chief of Family medicine department
• Study coordinator: Sean Lin
• Email: sean.lin@sunway.cc
• Phone: 02-27929568

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• WE CARE social needs screening and referral for families in primary care

  This project will test whether using the WE CARE social needs screening and referral program with an antiracist approach in family medicine can help reduce chronic conditions like diabetes, high blood pressure, depression, high cholesterol, and pediatric asthma for minoritized patients.

  Recruiting University of Massachusetts, Worcester · Worcester, Massachusetts and 2 other locations · NCT06903897

• Investigating the role of a protein in kidney damage related to nephrotic syndrome

  This study is trying to see if a protein called PCSK9 is linked to kidney damage and high cholesterol in people with nephrotic syndrome.

  Recruiting Kolding Sygehus · Kolding · NCT06373913

• Program to improve heart health in patients with high blood pressure and cholesterol

  This study is testing a six-month program to help people with high blood pressure and cholesterol improve their heart health using new support tools and strategies.

  Recruiting University of Pennsylvania · Philadelphia, Pennsylvania · NCT06062394

• Lifestyle medicine program to help rural adults with multiple chronic conditions

  This program will try supervised exercise and lifestyle coaching for rural adults aged 18–64 who have two or more chronic conditions to see if access to a wellness facility improves their health.

  Recruiting West Virginia School of Osteopathic Medicine · Lewisburg, West Virginia · NCT06049420

• Raising gut Akkermansia muciniphila with oral acetate (apple cider vinegar) during androgen deprivation therapy

  This tests whether taking oral acetate (apple cider vinegar) can raise Akkermansia muciniphila levels in the gut and help metabolic and bone health in men starting androgen deprivation therapy for metastatic castration‑sensitive prostate cancer.

  Recruiting Early Phase 1 Western University · London, Ontario · NCT05802121

• Understanding the causes of cerebral small vessel disease

  This study is trying to understand what causes cerebral small vessel disease by looking at brain changes in people who have had a stroke and are at risk for further issues over the next year.

  Recruiting Johns Hopkins University · Baltimore, Maryland · NCT05703386

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.